Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Guarino, Michael J
NCT01954992: Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer	Recruiting	3	480	US	Glufosfamide, Fluorouracil, 5-FU	Eleison Pharmaceuticals LLC.	Metastatic Pancreatic Adenocarcinoma	06/25	12/25
DORA, NCT03574571: A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer	Recruiting	3	738	Europe, US, RoW	Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223	Memorial Sloan Kettering Cancer Center, Bayer	Prostate Cancer	06/26	06/26